Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)
Condition: Basal Cell Nevus Syndrome Intervention: Drug: Patidegib Topical Gel, 2% Sponsor: PellePharm, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials